Mortality and causes of death in Italian persons with haemophilia, 1990-2007

Haemophilia

Volumn 16, Issue 3, 2010, Pages 437-446

  Tagliaferri, A ^a   Rivolta, G F ^a   Iorio, A ^b   Oliovecchio, E ^b   Mancuso, M E ^c   Morfini, M ^d   Rocino, A ^e   Mazzucconi, M G ^f   Franchini, M ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e San Giovanni Bosco Hospital   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cancer; Haemophilia; HCV; HIV; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COMORBIDITY; DISEASE ASSOCIATION; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HIV INFECTIONS; HUMANS; ITALY; LIFE EXPECTANCY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77953549604     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02188.x     Document Type: Article

References (27)

1. Mejia-Carvajal C, Czapek EE, Valentino LA. Life expectancy in hemophilia outcome. J Thromb Haemost 2006, 4:507-9.
2. Mannucci PM, Tuddenham EG. The hemophilias - from royal genes to gene therapy. N Engl J Med 2001, 344:1773-9.
3. Mannucci PM. Back to the future: a recent history of haemophilia treatment. Haemophilia 2008, 14(Suppl. 3):10-8.
4. Darby SC, Keeling DM, Spooner RJ. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004, 2:1047-54.
5. Street A, Hill K, Sussex B, Warner M, Scully MF. Haemophilia and ageing. Haemophilia 2006, 12(Suppl. 3):8-12.
6. Darby SC, Ewart DW, Giangrande PL. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 1997, 350:1425-31.
7. Chorba TL, Homan RC, Clarke MJ, Evatt BL. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. Am J Haematol 2001, 66:229-40.
8. Darby SC, Kan SW, Spooner RJ. The impact of HIV on mortality rates in the complete UK haemophilia population. AIDS 2004, 18:525-33.
9. Arnold DM, Julian JA, Walker IR. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up. Blood 2006, 108:460-4.
10. del Amo J, Perez-Hoyos S, Moreno A. Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease. J Acquir Immune Defic Syndr 2006, 41:624-31.
11. Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995. Haemophilia 1998, 4:714-20.
12. Soucie JM, Nuss R, Evatt B. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood 2000, 96:437-42.
13. Diamondstone LS, Aledort LM, Goedert JJ. Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders. Haemophilia 2002, 8:660-7.
14. Plug I, van der Bom JG, Peters M. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006, 4:510-6.
15. Darby SC, Kan SW, Spooner RJ. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007, 110:815-25.
16. Iorio A, Oliovecchio E, Morfini M, Mannucci PM. Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. Haemophilia 2008, 14:444-53.
17. Conwell Y, Forbes NT, Cox C, Caine ED. Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale. J Am Geriatr Soc 1993, 4:38-41.
18. Rothman KJ, Greenland S. Modern Epidemiology 1998, 2nd ed, Philadelphia, Lippincott-Raven
19. Miettinen OS. Estimability and estimation in casereferent studies. Am J Epidemiol 1976, 103:226-35.
20. Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis 1980, New York, John Wiley & Sons
21. Selvin S. Statistical Analysis of Epidemiologic Data 1996, New York, Oxford University Press
22. Cox DR. Regression models and life tables (with discussion). J Royal Stat Soc 1972, 34:187-220.
23. Siboni SM, Mannucci PM, Gringeri A. Health status and quality of life of elderly persons with severe haemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009, 7:780-6.
24. Reitter S, Waldhoer T, Vutuc C, Lechner K, Pabinger I. Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1983 to 2006. Haemophilia 2009, 15:888-93.
25. Mauser-Bunschoten EP, Fransen Van De Putte DE, Schutgens REG. Co-morbidity in the ageing haemoophilia: the down side of increased life expectancy. Haemophilia 2009, 15:853-63.
26. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens REG. Cardiovascular disease in patients with haemophilia. J Thromb Haemost 2009, 7:247-54.
27. Franchini M, Lippi G, Montagnana M. Haemophilia and cancer: A new challenge for hemophilia centers. Cancer Treat Rev 2009, 35:374-7.